Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share - Antidilutive effect (Details)

v3.24.1.u1
Net Loss per Share - Antidilutive effect (Details) - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 70,321,856 68,760,169
Options issued and outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 22,522,005 23,136,658
Warrants | July 16, 2021    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 14,324,893 14,324,994
Warrants | January 13, 2021    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 117,423 1,590,984
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 16,460,035 12,395,533
Unvested performance stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 0 414,500
Earn Out Shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 15,000,000 15,000,000
Contingently issuable common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 1,897,500 1,897,500